Cellebrite DI (CLBT) — Capital Reinvestment Ratio
Cellebrite DI (CLBT) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow ($82.23 Million) in capital expenditures ($3.96 Million). Check Cellebrite DI tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cellebrite DI Capital Reinvestment Ratio (2019–2025)
This chart tracks Cellebrite DI's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see CLBT cash flow conversion.
Annual Capital Reinvestment Ratio for Cellebrite DI (2019–2025)
Year-by-year Capital Reinvestment Ratio for Cellebrite DI from 2019 to 2025. See free cash flow generation of Cellebrite DI to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $168.96 Million | $13.22 Million | ▼ -2.5% |
| 2024 | 0.08x | $132.17 Million | $10.61 Million | ▲ +3.5% |
| 2023 | 0.08x | $102.06 Million | $7.92 Million | ▼ -82.4% |
| 2022 | 0.44x | $20.58 Million | $9.09 Million | ▲ +96.2% |
| 2021 | 0.22x | $36.05 Million | $8.11 Million | ▲ +142.1% |
| 2020 | 0.09x | $66.51 Million | $6.18 Million | ▼ -75.9% |
| 2019 | 0.38x | $16.13 Million | $6.21 Million | — |